| 2007 |
STRA6 was identified as a novel multi-transmembrane integral membrane protein. Structural analysis of missense mutations (P90L, P293L, T321P) suggested significant effects on the geometry of loops connecting transmembrane helices. Two C-terminal variations (T644M and R655C) alter an SH2-binding motif and a phosphorylation site, respectively, indicating these are functional sites. |
Homozygosity mapping, mutational analysis, structural modeling of transmembrane topology |
American journal of human genetics |
Medium |
17273977
|
| 1997 |
STRA6 encodes a highly hydrophobic membrane protein of a new type with no similarity to previously characterized integral membrane proteins. It is strongly expressed at blood-organ barriers (e.g., blood-testis barrier in Sertoli cells) with a spermatogenic cycle-dependent expression that is lost in RAR-alpha null mutants, suggesting it is a component of a retinoid transport machinery. |
Subtractive hybridization cDNA cloning, in situ hybridization, analysis of RAR-alpha null mutants |
Mechanisms of development |
Medium |
9203140
|
| 2008 |
STRA6-dependent transfer of retinol from RBP4 into NIH 3T3 fibroblasts was enhanced by lecithin:retinol acyltransferase (LRAT). Retinol transfer was shown to be bidirectional, establishing that STRA6 acts as a retinol channel/transporter. Loss-of-function in zebrafish revealed that Stra6 deficiency caused vitamin A deprivation of developing eyes. In the absence of Stra6, holo-Rbp4 provoked non-specific vitamin A excess in embryonic tissues, impairing retinoic acid receptor signaling. |
Cell-based retinol transfer assay with LRAT co-expression, zebrafish morpholino knockdown, pharmacological and morpholino RBP4 reduction |
Cell metabolism |
High |
18316031
|
| 2012 |
STRA6 functions as both a retinol transporter and a cytokine receptor. Activation of STRA6 signaling (JAK/STAT cascade) is triggered not simply by holo-RBP binding but by STRA6-mediated translocation of retinol from serum RBP to the intracellular acceptor CRBP-I. STRA6 phosphorylation is required for retinol uptake to proceed, demonstrating that signaling and transport are critically interdependent. |
Phosphorylation assays, CRBP-I interaction studies, retinol uptake assays with phosphorylation-deficient STRA6 mutants |
Molecular and cellular biology |
High |
22665496
|
| 2012 |
Transthyretin (TTR) blocks the ability of holo-RBP to associate with STRA6, thereby suppressing both STRA6-mediated retinol uptake and STRA6-initiated JAK/STAT cell signaling. TTR protects mice from RBP-induced insulin resistance. STRA6 functions only when plasma RBP levels exceed TTR levels. |
Cell-based retinol uptake assay, JAK/STAT signaling assays, glucose tolerance tests in mice with TTR manipulation |
Molecular and cellular biology |
High |
22826435
|
| 2012 |
STRA6 catalyzes bidirectional retinol transport: (1) influx — retinol release from holo-RBP coupled to CRBP-I or LRAT; (2) efflux — loading of free retinol into apo-RBP, driven by CRBP-I. Holo-RBP blocks STRA6-mediated efflux by competing with apo-RBP binding. STRA6 also catalyzes efficient retinol exchange between intracellular CRBP-I and extracellular RBP. |
In vitro retinol transport assays with purified components, competition binding assays |
The Journal of membrane biology |
High |
22815070
|
| 2013 |
Lecithin:retinol acyl transferase (LRAT), which esterifies retinol to retinyl esters, is necessary for activation of the STRA6/JAK2/STAT5 signaling cascade by holo-RBP. LRAT-null mice are protected from holo-RBP-induced suppression of insulin responses, establishing that STRA6 signaling requires retinol esterification to drive inward transport. |
LRAT-null mouse model, JAK2/STAT5 phosphorylation assays, insulin response measurements |
FASEB journal |
High |
24036882
|
| 2013 |
STRA6 functions as a cytokine receptor activating JAK2 and the transcription factors STAT3 and STAT5 upon holo-RBP binding. This signaling promotes oncogenic transformation and is critical for tumor formation by colon carcinoma cells in vivo. |
JAK2/STAT3/STAT5 phosphorylation assays, oncogenic transformation assay in fibroblasts, xenograft mouse model with STRA6 knockdown |
Cancer research |
Medium |
25237067
|
| 2013 |
STRA6 mediates bidirectional retinol transport in adipocyte precursors: holo-RBP4 triggers retinol influx and blocks adipocyte differentiation by activating RARα, while apo-RBP4 triggers retinol efflux, reducing cellular retinoids and RARα activity, thereby enhancing adipogenesis. Ectopic STRA6 synergized with apo-RBP4 to enhance adipogenesis. |
Cell-based retinol efflux/influx assays, RARα reporter assays, adipocyte differentiation assays, mouse liver RBP4 mobilization experiment |
Molecular and cellular biology |
High |
23959802
|
| 2013 |
STRA6 is essential for RBP-induced suppression of insulin signaling in vivo; Stra6-null mice are protected from RBP-induced insulin resistance. However, with the exception of the eye, ablation of Stra6 had only a modest effect on retinoid homeostasis in other tissues, demonstrating that STRA6's primary systemic function (outside the eye) is coupling circulating holo-RBP to JAK/STAT cell signaling rather than retinol delivery. |
Stra6-null mouse model, retinoid quantification by HPLC, insulin signaling assays, glucose tolerance tests |
The Journal of biological chemistry |
High |
23839944
|
| 2013 |
Stra6 can be upregulated by DNA damage in a p53-dependent manner and plays a role in p53-induced apoptosis. Stra6 expression induced mitochondrial depolarization and accumulation of reactive oxygen species; inhibition of Stra6 compromised p53-induced apoptosis. These functions did not require downstream activation of retinoic acid signaling. |
DNA damage assays, p53-dependent transcriptional analysis, apoptosis assays, ROS measurement, mitochondrial membrane potential assay, Stra6 knockdown |
Cell death and differentiation |
Medium |
23449393
|
| 2014 |
STRA6 is a bona fide vitamin A transporter critical for ocular vitamin A uptake. Stra6-knockout mice show markedly reduced ocular retinoids, malformations in the choroid and RPE, early cone photoreceptor cell death, and reduced rod outer segment length. STRA6-mediated uptake in the eye is a regulated process mandatory when RBP4 is the only transport mode. Vitamin A transport through the blood-CSF barrier in the choroid plexus was also impaired. |
Stra6-knockout mouse model, HPLC retinoid quantification, ophthalmic imaging, histology, electroretinography, pharmacological vitamin A rescue |
Human molecular genetics |
High |
24852372
|
| 2014 |
The STRA6 G304K mutant protein is mislocalized and has severely reduced vitamin A uptake activity, establishing that membrane localization is required for STRA6 function. Inhibiting retinoic acid synthesis in zebrafish reproduced the colobomatous microanophthalmia phenotype, confirming diminished RA levels underlie the eye malformations. |
STRA6 G304K mutant expression and localization analysis, retinol uptake assay, zebrafish RA synthesis inhibition model |
Human mutation |
Medium |
21901792
|
| 2016 |
Cryo-EM structure of zebrafish STRA6 determined at 3.9 Å resolution revealed: (1) STRA6 has one intramembrane and nine transmembrane helices in a homodimeric assembly; (2) calmodulin is tightly bound to STRA6 in a noncanonical arrangement; (3) residues involved in RBP binding map to an arch-like structure covering a deep lipophilic cleft; (4) the cleft is open to the membrane, suggesting retinol internalization via direct diffusion into the lipid bilayer. |
Single-particle cryo-electron microscopy at 3.9 Å resolution |
Science |
High |
27563101
|
| 2016 |
STRA6 is critical for vitamin A transport across blood-tissue barriers in the eyes, brain, and testis. In Stra6-knockout mice under vitamin A-deficient conditions, retinoid homeostasis in the eye, brain, and testis (but not in fat or lung) was severely impaired. Stra6 expression in testis and brain was regulated by vitamin A supply, reducing consumption when dietary supply was limited. |
Stra6-knockout mouse model with controlled dietary vitamin A, retinoid quantification in multiple tissues, retinoid-dependent physiological assays |
FASEB journal |
High |
27189978
|
| 2017 |
STRA6 mediates the inhibitory effect of RBP4 on insulin synthesis in pancreatic β-cells through the JAK2/STAT1/ISL-1 signaling pathway. STRA6 is expressed in β-cells and its activation by RBP4 suppresses glucose-stimulated insulin secretion. |
Primary islet isolation, INS-1E cell culture, RBP4 transgenic mouse model, JAK2/STAT1/ISL-1 pathway analysis, siRNA knockdown of STRA6 |
Diabetes |
Medium |
33199363
|
| 2017 |
STRA6 activates JAK2-STAT3 signaling to promote colon cancer stem cell maintenance. Downregulation of STRA6 or RBP4 decreased cancer stem cell fraction and sphere and tumor initiation frequency. High-fat diet increased STRA6 levels and promoted tumor growth. |
STRA6 knockdown in colon cancer cells, sphere formation assay, xenograft tumor initiation assay, JAK2-STAT3 signaling analysis |
Stem cell reports |
Medium |
28689994
|
| 2017 |
Adipose tissue STRA6 undergoes circadian patterning driven in part by the nuclear transcription factor REV-ERBα. STRA6 is necessary for diurnal rhythmicity of insulin action and JAK/STAT signaling in adipose tissue. |
Circadian expression analysis of STRA6, REV-ERBα manipulation, adipose-specific STRA6 knockout mouse, insulin action and JAK/STAT signaling assays at different circadian time points |
The Journal of biological chemistry |
Medium |
28733465
|
| 2021 |
Ca2+-calmodulin binding to STRA6 is mediated via the BP2 intracellular helix region. At resting intracellular Ca2+ levels (<100 nM), BP2 binds only the C-lobe of calmodulin. As Ca2+ approaches 1000 nM (signaling levels), BP2 interacts with both N- and C-lobes of Ca2+-loaded calmodulin. BP2 binding increases Ca2+-binding affinity of calmodulin and slows Ca2+ dissociation rates in both lobes. |
NMR chemical shift perturbation mapping, isothermal titration calorimetry, kinetic Ca2+ binding studies with BP2 peptide derived from STRA6 |
Journal of molecular biology |
High |
34592217
|
| 2019 |
O-GlcNAcylation of STRA6 in diabetic kidneys significantly modifies STRA6, suppresses RBP4 binding activity, and disrupts retinol signals (CRBP1, LRAT, retinol, retinoic acid, RARs). Blocking O-GlcNAcylation with OSMI-1 or OGA overexpression restored STRA6 function and retinol signals. |
Co-immunoprecipitation, proximity ligation assay, Western blot, HPLC retinoid measurement, OGT/OGA siRNA, TMG/OSMI-1 pharmacological manipulation in db/db and ob/ob mice and HK-2 cells |
Biochimica et biophysica acta. General subjects |
Medium |
30905621
|
| 2021 |
STRA6 mediates retinol transfer from hepatic stellate cells (HSCs) to hepatocytes during liver fibrosis. TIF1γ suppression in HSCs upregulates STRA6 and promotes retinol release; hepatocytes take up retinol via STRA6, leading to lipogenesis (upregulation of lipogenesis-related genes and triglyceride accumulation). STRA6 knockdown in vivo reduced liver fibrosis. |
siRNA knockdown of STRA6 in LX2 cells, HepG2 retinol uptake assay, RAR antagonist, in vivo siSTRA6 treatment in TAA fibrosis model, Lrat:Cas9-ERT2:sgTif1γ mice |
Cell & bioscience |
Medium |
33407858
|
| 2023 |
STRA6 is essential for proper induction of vascular smooth muscle cell (SMC) lineages from human cardiac progenitors. STRA6-knockout hESCs could differentiate into cardiomyocytes normally but failed to differentiate into mesodermal- or neural crest-derived SMCs. A previously unrecognized interaction between RA nuclear receptors RARα/RXRα and TBX1 (an OFT-specific transcription factor) was identified as a downstream effector of STRA6-mediated RA signaling. |
STRA6-knockout hESC differentiation assays, population RNA-seq, co-immunoprecipitation of RARα/RXRα with TBX1, single-cell RNA-seq comparison of human and murine embryonic hearts |
Cardiovascular research |
Medium |
36635482
|
| 2022 |
STRA6 is critical for adjusting the stoichiometry of chromophore and opsins in rod and cone photoreceptors. In STRA6-deficient mice, decreased chromophore led to downregulation of opsin genes in rods and absent/mislocalized opsins in cones. Rod photoreceptors entrapped available chromophore but showed significant amounts of chromophore-free opsins. Vitamin A supplementation ameliorated rod but not cone phenotype. |
Stra6-knockout mouse model, retinoid quantification, opsin gene expression analysis, immunolocalization of opsins, electroretinography, pharmacological vitamin A rescue |
Human molecular genetics |
High |
34508587
|
| 2024 |
RBP4 promotes muscle atrophy through a STRA6-dependent JAK2/STAT3 pathway. Holo-RBP4 upregulated STRA6 expression (>3-fold) and promoted phosphorylation of JAK2 and STAT3. Inhibition of STRA6, JAK2, or STAT3 by siRNA or inhibitors decreased expression of atrophy markers Atrogin-1 and MuRF1, and decreased expression of myogenesis regulators MyoD and MyoG in holo-RBP4-treated C2C12 myotubes. |
siRNA knockdown of STRA6/JAK2/STAT3, specific signaling inhibitors, C2C12 myotube assays, RBP4-knockout mouse model, denervation-induced atrophy model, intramuscular injection of holo-RBP4 |
Journal of cachexia, sarcopenia and muscle |
Medium |
39031684
|
| 2024 |
STRA6 interacts with integrin-linked kinase (ILK) and subsequently activates the AKT/mTOR signaling pathway in thyroid carcinoma, promoting cell proliferation and metastasis. STRA6 also reprograms lipid metabolism through SREBP1 downstream of this axis. |
Co-immunoprecipitation of STRA6 with ILK, RNA sequencing, STRA6 stable knockdown, in vitro proliferation/metastasis assays, xenograft model, LNP-siRNA delivery |
Endocrinology |
Medium |
36592123
|
| 2024 |
STRA6 mRNA stability is regulated by m6A modification: VIRMA (an m6A methyltransferase) targets the 3' UTR of STRA6 mRNA, and the m6A reader IGF2BP2 stabilizes STRA6 mRNA. VIRMA-driven STRA6 upregulation promotes STAT3 activation and HIF-1α-dependent glycolysis in pancreatic ductal adenocarcinoma. |
m6A sequencing, RNA sequencing, RIP-seq, mRNA stability assays, IGF2BP2 interaction studies, in vitro and in vivo PDAC models |
Cancer letters |
Medium |
38604311
|
| 2014 |
STRA6 promotes Wnt/β-catenin signaling in gastric cancer. STRA6 knockdown inhibited the Wnt/β-catenin signaling pathway. STRA6 was confirmed as a direct target of miR-873, which suppresses GC tumor progression. |
STRA6 knockdown, Wnt/β-catenin pathway reporter assays, dual-luciferase reporter assay confirming miR-873 targeting of STRA6, rescue assays |
Journal of experimental & clinical cancer research |
Low |
31694721
|
| 2015 |
Purified recombinant STRA6 interacts with RBP in a retinol-independent manner as determined by surface plasmon resonance, with binding data consistent with a transient interaction of 1 mole RBP per mole STRA6. |
Surface plasmon resonance-based binding analysis of purified STRA6-GFP produced in Pichia pastoris |
PloS one |
Medium |
25816144
|
| 2020 |
STRA6 promotes NSCLC cell growth by activating JAK2/STAT3 signaling, which induces STAT3 target gene SREBP-1c expression, thereby promoting SREBP-1-mediated lipogenesis and providing energy for cancer cell growth. |
STRA6 knockdown in NSCLC cell lines and mouse xenograft, STAT3/SREBP-1 pathway analysis, lipid metabolism assays |
Molecular and cellular biochemistry |
Low |
39168951
|
| 2025 |
STRA6 and melanin act synergistically to preserve the integrity of the outer blood-retinal barrier (oBRB). In albino Stra6-knockout mice, dietary vitamin A via chylomicrons failed to compensate for the loss of RBP4-mediated transport, leading to functional impairment of rod and cone responses and downregulation of tight junction proteins (ZO-1, Claudin-1, Claudin-3). Treatment with the pan-RAR agonist TTNPB restored junctional gene expression and oBRB function, demonstrating that barrier failure arises from impaired retinoid signaling. |
Albino Stra6-knockout mouse model, retinoid quantification, tight junction protein Western blot and immunofluorescence, electroretinography, TTNPB pharmacological rescue |
The Journal of biological chemistry |
High |
41135684
|
| 2024 |
In STRA6-deficient mice, light-induced loss of ocular retinoids and visual impairment were correlated with generation of visual cycle byproducts (9-cis-retinal, 13-cis-retinal). 9-cis-retinal was recycled to all-trans-retinal via isorhodopsin. The absence of STRA6 impaired replenishment of retinoids lost through these chemical side reactions. |
Stra6-knockout mouse model, light bleaching experiments, HPLC retinoid quantification, rhodopsin spectrophotometry, electroretinography |
The Journal of biological chemistry |
Medium |
38395306
|
| 2014 |
An alternative downstream promoter of Stra6 contains a half-site RA response element (RARE) required for RA-induced transcription. CRISPR-Cas9 editing of the endogenous RARE abolished RA-induced transcription of both Stra6 isoforms. RARγ and RXRα bind the Stra6 RARE; RA increases co-activator p300 binding and H3K27 acetylation while decreasing Suz12 and H3K27 trimethylation at both promoters, and these epigenetic changes depend on RARγ. |
CRISPR-Cas9 genome editing of endogenous RARE, ChIP-seq for RARγ/RXRα/p300/Suz12, luciferase reporter assay, analysis of RARγ-null mice and vitamin A-deficient mice |
The Journal of biological chemistry |
High |
25544292
|
| 2001 |
Stra6 is synergistically induced by Wnt-1 signaling and retinoic acid in mammary cells. Wnt-1 upregulates retinoic acid receptor-gamma (RAR-gamma), which partly explains this synergy. Treatment of human colorectal cancer cell lines with retinoic acid led to accumulation of Stra6 protein at the cell membrane. |
mRNA screening of Wnt-1-stimulated C57MG cells, retinoic acid treatment of colorectal cancer cell lines, RAR-gamma upregulation analysis |
Cancer research |
Low |
11358845
|